Cargando…
Evaluation of serum and cerebrospinal fluid biomarkers after vaccination against SARS‐CoV‐2
OBJECTIVE: Vaccines are a major achievement of science, and new vaccines against SARS‐CoV‐2 are protecting the entire population from a life‐threatening infection. Although several neurological complications or worsening of pre‐existing neurological conditions after vaccination have been observed, w...
Autores principales: | Iacono, Salvatore, Piccoli, Tommaso, Aridon, Paolo, Schirò, Giuseppe, Blandino, Valeria, Tarantino, Domenico, Agnello, Luisa, Ciaccio, Marcello, Ragonese, Paolo, Salemi, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10270270/ https://www.ncbi.nlm.nih.gov/pubmed/37139906 http://dx.doi.org/10.1002/acn3.51785 |
Ejemplares similares
-
A Brief Overview on BDNF-Trk Pathway in the Nervous System: A Potential Biomarker or Possible Target in Treatment of Multiple Sclerosis?
por: Schirò, Giuseppe, et al.
Publicado: (2022) -
Identification of Biomarkers in Cerebrospinal Fluid and Serum of Multiple Sclerosis Patients by Immunoproteomics Approach
por: Colomba, Paolo, et al.
Publicado: (2014) -
The Role of Nutritional Lifestyle and Physical Activity in Multiple Sclerosis Pathogenesis and Management: A Narrative Review
por: Fanara, Salvatore, et al.
Publicado: (2021) -
High Cerebrospinal Fluid CX3CL1 Levels in Alzheimer’s Disease Patients but Not in Non-Alzheimer’s Disease Dementia
por: Bivona, Giulia, et al.
Publicado: (2022) -
Stroke incidence and case fatality: a 9-year prospective population-based study in an elderly population of Bagheria, Italy
por: Arnao, Valentina, et al.
Publicado: (2020)